Li, H.; Ibrahim, M.M.; Chen, H.; Li, W.; Jablonski, M.M.
In Silico Screening and In Vivo Evaluation of Potential CACNA2D1 Antagonists as Intraocular Pressure-Reducing Agents in Glaucoma Therapy. Pharmaceuticals 2021, 14, 887.
https://doi.org/10.3390/ph14090887
AMA Style
Li H, Ibrahim MM, Chen H, Li W, Jablonski MM.
In Silico Screening and In Vivo Evaluation of Potential CACNA2D1 Antagonists as Intraocular Pressure-Reducing Agents in Glaucoma Therapy. Pharmaceuticals. 2021; 14(9):887.
https://doi.org/10.3390/ph14090887
Chicago/Turabian Style
Li, Hanxuan, Mohamed Moustafa Ibrahim, Hao Chen, Wei Li, and Monica M. Jablonski.
2021. "In Silico Screening and In Vivo Evaluation of Potential CACNA2D1 Antagonists as Intraocular Pressure-Reducing Agents in Glaucoma Therapy" Pharmaceuticals 14, no. 9: 887.
https://doi.org/10.3390/ph14090887
APA Style
Li, H., Ibrahim, M. M., Chen, H., Li, W., & Jablonski, M. M.
(2021). In Silico Screening and In Vivo Evaluation of Potential CACNA2D1 Antagonists as Intraocular Pressure-Reducing Agents in Glaucoma Therapy. Pharmaceuticals, 14(9), 887.
https://doi.org/10.3390/ph14090887